Regulatory challenges and current policy for cardiotoxicity detection in oncology drug development.
Journal: Journal of thrombosis and thrombolysis
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Becker RC (2026). "Regulatory challenges and current policy for cardiotoxicity detection in oncology drug development.". Journal of thrombosis and thrombolysis. https://doi.org/10.1007/s11239-026-03337-w